Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aspirin or Heparin or Both for Improving Pregnancy Outcomes in Women With Persistent Antiphospholipid Antibodies and Recurrent Pregnancy Loss." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/. Accessed 16 May 2024.
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/. Accessed May 16, 2024.
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/
Aspirin or Heparin or Both for Improving Pregnancy Outcomes in Women With Persistent Antiphospholipid Antibodies and Recurrent Pregnancy Loss [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
ID - 433348
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/
DB - Evidence Central
DP - Unbound Medicine
ER -